Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death and the sixth most diagnosed malignancy worldwide. Serum alpha-fetoprotein (AFP) is the traditional, ubiquitous biomarker for HCC. However, there has been an increasing call for the use of multiple biomarkers to optimi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancers 2024-04, Vol.16 (8), p.1453
Hauptverfasser:	Fares, Sami, Wehrle, Chase J, Hong, Hanna, Sun, Keyue, Jiao, Chunbao, Zhang, Mingyi, Gross, Abby, Allkushi, Erlind, Uysal, Melis, Kamath, Suneel, Ma, Wen Wee, Modaresi Esfeh, Jamak, Linganna, Maureen Whitsett, Khalil, Mazhar, Pita, Alejandro, Kim, Jaekeun, Walsh, R Matthew, Miller, Charles, Hashimoto, Koji, Schlegel, Andrea, Kwon, David Choon Hyuck, Aucejo, Federico
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Glycosylation Hepatocellular carcinoma Liver cancer Liver cirrhosis Liver transplants Malignancy Medical prognosis Metabolomics Patients Prothrombin Surveillance Tumors Vitamin K α-Fetoprotein
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!